<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">37486226</PMID><DateCompleted><Year>2023</Year><Month>08</Month><Day>23</Day></DateCompleted><DateRevised><Year>2023</Year><Month>10</Month><Day>03</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1550-6606</ISSN><JournalIssue CitedMedium="Internet"><Volume>211</Volume><Issue>5</Issue><PubDate><Year>2023</Year><Month>Sep</Month><Day>01</Day></PubDate></JournalIssue><Title>Journal of immunology (Baltimore, Md. : 1950)</Title><ISOAbbreviation>J Immunol</ISOAbbreviation></Journal><ArticleTitle>Molecular Mechanisms of Lupus Susceptibility Allele PBX1D.</ArticleTitle><Pagination><StartPage>727</StartPage><EndPage>734</EndPage><MedlinePgn>727-734</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.4049/jimmunol.2300362</ELocationID><Abstract><AbstractText>Pre-B cell leukemia homeobox 1 (PBX1) controls chromatin accessibility to a large number of genes in various cell types. Its dominant negative splice isoform, PBX1D, which lacks the DNA and Hox-binding domains, is expressed more frequently in the CD4+ T cells from lupus-prone mice and patients with systemic lupus erythematosus than healthy control subjects. PBX1D overexpression in CD4+ T cells impaired regulatory T cell homeostasis and expanded inflammatory CD4+ T cells. In this study, we showed that PBX1 message expression is downregulated by activation in CD4+ T cells as well as in B cells. PBX1D protein was less stable than the normal isoform, PBX1B, and it is degraded through the ubiquitin-proteasome-dependent pathway. The DNA binding domain lacking in PBX1D has two putative ubiquitin binding sites, K292 and K293, that are predicted to be in direct contact with DNA. Mutation of K292-293 reduced PBX1B stability to a level similar to PBX1D and abrogated DNA binding. In addition, contrary to PBX1B, PBX1D is retained in the cytoplasm without the help of the cofactors MEIS or PREP1, indicating a different requirement for nuclear translocation. Overall, these findings suggest that multiple post-transcriptional mechanisms are responsible for PBX1D loss of function and induction of CD4+ T cell inflammatory phenotypes in systemic lupus erythematosus.</AbstractText><CopyrightInformation>Copyright &#xa9; 2023 by The American Association of Immunologists, Inc.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Park</LastName><ForeName>Yuk Pheel</ForeName><Initials>YP</Initials><Identifier Source="ORCID">0000-0001-9749-5983</Identifier><AffiliationInfo><Affiliation>Department of Microbiology, Immunology, and Molecular Genetics, University of Texas Health, San Antonio, TX.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Roach</LastName><ForeName>Tracoyia</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Department of Pathology, Immunology and Laboratory Medicine, College of Medicine, University of Florida, Gainesville, FL.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Soh</LastName><ForeName>Sujung</ForeName><Initials>S</Initials><Identifier Source="ORCID">0000-0001-9576-6524</Identifier><AffiliationInfo><Affiliation>Research Institute of Women's Health, Sookmyung Women's University, Yongsan-Gu, Seoul, South Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zeumer-Spataro</LastName><ForeName>Leilani</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Department of Pathology, Immunology and Laboratory Medicine, College of Medicine, University of Florida, Gainesville, FL.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Choi</LastName><ForeName>Seung-Chul</ForeName><Initials>SC</Initials><AffiliationInfo><Affiliation>Department of Microbiology, Immunology, and Molecular Genetics, University of Texas Health, San Antonio, TX.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ostrov</LastName><ForeName>David A</ForeName><Initials>DA</Initials><Identifier Source="ORCID">0000-0002-4696-875X</Identifier><AffiliationInfo><Affiliation>Department of Pathology, Immunology and Laboratory Medicine, College of Medicine, University of Florida, Gainesville, FL.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yang</LastName><ForeName>Young</ForeName><Initials>Y</Initials><Identifier Source="ORCID">0000-0003-4239-0804</Identifier><AffiliationInfo><Affiliation>Research Institute of Women's Health, Sookmyung Women's University, Yongsan-Gu, Seoul, South Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Morel</LastName><ForeName>Laurence</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Department of Microbiology, Immunology, and Molecular Genetics, University of Texas Health, San Antonio, TX.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>R01 AI045050</GrantID><Acronym>AI</Acronym><Agency>NIAID NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>J Immunol</MedlineTA><NlmUniqueID>2985117R</NlmUniqueID><ISSNLinking>0022-1767</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D018398">Homeodomain Proteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000075062">Pre-B-Cell Leukemia Transcription Factor 1</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D020033">Protein Isoforms</NameOfSubstance></Chemical><Chemical><RegistryNumber>9007-49-2</RegistryNumber><NameOfSubstance UI="D004247">DNA</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D014452">Ubiquitins</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D051379" MajorTopicYN="N">Mice</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018398" MajorTopicYN="Y">Homeodomain Proteins</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000075062" MajorTopicYN="N">Pre-B-Cell Leukemia Transcription Factor 1</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000483" MajorTopicYN="N">Alleles</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D020033" MajorTopicYN="N">Protein Isoforms</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008180" MajorTopicYN="Y">Lupus Erythematosus, Systemic</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004247" MajorTopicYN="N">DNA</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014452" MajorTopicYN="N">Ubiquitins</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading></MeshHeadingList><CoiStatement>Conflict of Interest. The authors declare no conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>5</Month><Day>30</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>7</Month><Day>3</Day></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>9</Month><Day>1</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>8</Month><Day>23</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>7</Month><Day>24</Day><Hour>13</Hour><Minute>7</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>7</Month><Day>24</Day><Hour>10</Hour><Minute>3</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37486226</ArticleId><ArticleId IdType="mid">NIHMS1915815</ArticleId><ArticleId IdType="pmc">PMC10530199</ArticleId><ArticleId IdType="doi">10.4049/jimmunol.2300362</ArticleId><ArticleId IdType="pii">265793</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Fairhurst AM, Wandstrat AE, and Wakeland EK. 2006. Systemic lupus erythematosus: multiple immunological phenotypes in a complex genetic disease. Adv. Immunol 92: 1&#x2013;69.</Citation><ArticleIdList><ArticleId IdType="pubmed">17145301</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen Y, Cuda C, and Morel L. 2005. Genetic determination of T cell help in loss of tolerance to nuclear antigens. J. Immunol 174: 7692&#x2013;7702.</Citation><ArticleIdList><ArticleId IdType="pubmed">15944270</ArticleId></ArticleIdList></Reference><Reference><Citation>Cuda CM, Wan S, Sobel ES, Croker BP, and Morel L. 2007. Murine lupus susceptibility locus Sle1a controls regulatory T cell number and function through multiple mechanisms. J. Immunol 179: 7439&#x2013;7447.</Citation><ArticleIdList><ArticleId IdType="pubmed">18025188</ArticleId></ArticleIdList></Reference><Reference><Citation>Cuda CM, Zeumer L, Sobel ES, Croker BP, and Morel L. 2010. Murine lupus susceptibility locus Sle1a requires the expression of two sub-loci to induce inflammatory T cells. Genes Immun. 11: 542&#x2013;553.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2958247</ArticleId><ArticleId IdType="pubmed">20445563</ArticleId></ArticleIdList></Reference><Reference><Citation>Grebbin BM, and Schulte D. 2017. PBX1 as pioneer factor: A Case still open. Front Cell. Dev. Biol 5: 9.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5306212</ArticleId><ArticleId IdType="pubmed">28261581</ArticleId></ArticleIdList></Reference><Reference><Citation>DiMartino JF, Selleri L, Traver D, Firpo MT, Rhee J, Warnke R, O&#x2019;Gorman S, Weissman IL, and Cleary ML. 2001. The Hox cofactor and proto-oncogene Pbx1 is required for maintenance of definitive hematopoiesis in the fetal liver. Blood. 98: 618&#x2013;626.</Citation><ArticleIdList><ArticleId IdType="pubmed">11468159</ArticleId></ArticleIdList></Reference><Reference><Citation>Schnabel CA, Selleri L, Jacobs Y, Warnke R, and Cleary ML. 2001. Expression of Pbx1b during mammalian organogenesis. Mech. Develop 100: 131&#x2013;135.</Citation><ArticleIdList><ArticleId IdType="pubmed">11118899</ArticleId></ArticleIdList></Reference><Reference><Citation>Sanyal M, Tung JW, Karsunky H, Zeng H, Selleri L, Weissman IL, Herzenberg LA, and Cleary ML. 2007. B-cell development fails in the absence of the Pbx1 proto-oncogene. Blood. 109: 4191&#x2013;4199.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1885499</ArticleId><ArticleId IdType="pubmed">17244677</ArticleId></ArticleIdList></Reference><Reference><Citation>Xu X, Zhou Y, Fu B, Zhang J, Dong Z, Zhang X, Shen N, Sun R, Tian Z, and Wei H. 2020. PBX1 promotes development of natural killer cells by binding directly to the Nfil3 promoter. Faseb J. 34: 6479&#x2013;6492.</Citation><ArticleIdList><ArticleId IdType="pubmed">32190943</ArticleId></ArticleIdList></Reference><Reference><Citation>Ficara F, Murphy MJ, Lin M, and Cleary ML. 2008. Pbx1 regulates self-renewal of long-term hematopoietic stem cells by maintaining their quiescence. Cell Stem Cell. 2: 484&#x2013;496.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2416441</ArticleId><ArticleId IdType="pubmed">18462698</ArticleId></ArticleIdList></Reference><Reference><Citation>Gordon JA, Hassan MQ, Saini S, Montecino M, van Wijnen AJ, Stein GS, Stein JL, and Lian JB. 2010. Pbx1 represses osteoblastogenesis by blocking Hoxa10-mediated recruitment of chromatin remodeling factors. Mol. Cell. Biol 30: 3531&#x2013;3541.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2897555</ArticleId><ArticleId IdType="pubmed">20439491</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou Y, Fu B, Xu X, Zhang J, Tong X, Wang Y, Dong Z, Zhang X, Shen N, Zhai Y, Kong X, Sun R, Tian Z, and Wei H. 2020. PBX1 expression in uterine natural killer cells drives fetal growth. Sci. Transl. Med 12:(537) eaax1798.</Citation><ArticleIdList><ArticleId IdType="pubmed">32238574</ArticleId></ArticleIdList></Reference><Reference><Citation>Le Tanno P, Breton J, Bidart M, Satre V, Harbuz R, Ray PF, Bosson C, Dieterich K, Jaillard S, Odent S, Poke G, Beddow R, Digilio MC, Novelli A, Bernardini L, Pisanti MA, Mackenroth L, Hackmann K, Vogel I, Christensen R, Fokstuen S, Bena F, Amblard F, Devillard F, Vieville G, Apostolou A, Jouk PS, Guebre-Egziabher F, Sartelet H, and Coutton C. 2017. PBX1 haploinsufficiency leads to syndromic congenital anomalies of the kidney and urinary tract (CAKUT) in humans. J. Med. Genet 54: 502&#x2013;510.</Citation><ArticleIdList><ArticleId IdType="pubmed">28270404</ArticleId></ArticleIdList></Reference><Reference><Citation>Veiga RN, de Oliveira JC, and Gradia DF. 2021. PBX1: a key character of the hallmarks of cancer. J. Mol. Med 99: 1667&#x2013;1680.</Citation><ArticleIdList><ArticleId IdType="pubmed">34529123</ArticleId></ArticleIdList></Reference><Reference><Citation>Cuda CM, Li S, Liang S, Yin Y, Potula HH, Xu Z, Sengupta M, Chen Y, Butfiloski E, Baker H, Chang LJ, Dozmorov I, Sobel ES, and Morel L. 2012. Pre-B cell leukemia homeobox 1 is associated with lupus susceptibility in mice and humans. J. Immunol 188: 604&#x2013;614.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3253202</ArticleId><ArticleId IdType="pubmed">22180614</ArticleId></ArticleIdList></Reference><Reference><Citation>Sengupta M, Liang S, Potula HH, Chang LJ, and Morel L. 2012. The SLE-associated Pbx1-d isoform acts as a dominant-negative transcriptional regulator. Genes Immun. 13: 653&#x2013;657.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3600587</ArticleId><ArticleId IdType="pubmed">22992721</ArticleId></ArticleIdList></Reference><Reference><Citation>Penkov D, Mateos San Martin D, Fernandez-Diaz LC, Rossello CA, Torroja C, Sanchez-Cabo F, Warnatz HJ, Sultan M, Yaspo ML, Gabrieli A, Tkachuk V, Brendolan A, Blasi F, and Torres M. 2013. Analysis of the DNA-binding profile and function of TALE homeoproteins reveals their specialization and specific interactions with Hox genes/proteins. Cell Rep. 3: 1321&#x2013;1333.</Citation><ArticleIdList><ArticleId IdType="pubmed">23602564</ArticleId></ArticleIdList></Reference><Reference><Citation>Choi SC, Hutchinson TE, Titov AA, Seay HR, Li S, Brusko TM, Croker BP, Salek-Ardakani S, and Morel L. 2016. The lupus susceptibility gene Pbx1 regulates the balance between follicular helper T cell and regulatory T cell differentiation. J. Immunol 197: 458&#x2013;469.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4935607</ArticleId><ArticleId IdType="pubmed">27296664</ArticleId></ArticleIdList></Reference><Reference><Citation>Li W, Elshikha AS, Cornaby C, Teng X, Abboud G, Brown J, Zou X, Zeumer-Spataro L, Robusto B, Choi SC, Fredenburg K, Major A, and Morel L. 2020. T cells expressing the lupus susceptibility allele Pbx1d enhance autoimmunity and atherosclerosis in dyslipidemic mice. JCI Insight. 5(11): e138274.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7308052</ArticleId><ArticleId IdType="pubmed">32493841</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhu Q, Yu T, Gan S, Wang Y, Pei Y, Zhao Q, Pei S, Hao S, Yuan J, Xu J, Hou F, Wu X, Peng C, Wu P, Qin J, and Xiao Y. 2020. TRIM24 facilitates antiviral immunity through mediating K63-linked TRAF3 ubiquitination. J. Exp. Med 217 (7): e20192083.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7336305</ArticleId><ArticleId IdType="pubmed">32324863</ArticleId></ArticleIdList></Reference><Reference><Citation>Emsley P, and Cowtan K. 2004. Coot: model-building tools for molecular graphics. Acta Crystallogr D Biol Crystallogr 60: 2126&#x2013;2132.</Citation><ArticleIdList><ArticleId IdType="pubmed">15572765</ArticleId></ArticleIdList></Reference><Reference><Citation>LaRonde-LeBlanc NA, and Wolberger C. 2003. Structure of HoxA9 and Pbx1 bound to DNA: Hox hexapeptide and DNA recognition anterior to posterior. Genes Dev. 17: 2060&#x2013;2072.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC196259</ArticleId><ArticleId IdType="pubmed">12923056</ArticleId></ArticleIdList></Reference><Reference><Citation>Larson CL, and Heinzen RA. 2017. High-Content Imaging Reveals Expansion of the Endosomal Compartment during Coxiella burnetii Parasitophorous Vacuole Maturation. Front Cell Infect. Microbiol 7: 48.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5329641</ArticleId><ArticleId IdType="pubmed">28293541</ArticleId></ArticleIdList></Reference><Reference><Citation>Carpenter AE, Jones TR, Lamprecht MR, Clarke C, Kang IH, Friman O, Guertin DA, Chang JH, Lindquist RA, Moffat J, Golland P, and Sabatini DM. 2006. CellProfiler: image analysis software for identifying and quantifying cell phenotypes. Genome Biol. 7: R100.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1794559</ArticleId><ArticleId IdType="pubmed">17076895</ArticleId></ArticleIdList></Reference><Reference><Citation>Janssen AFJ, Breusegem SY, and Larrieu D. 2022. Current methods and pipelines for image-based quantitation of nuclear shape and nuclear envelope abnormalities. Cells 11(3): 47.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8834579</ArticleId><ArticleId IdType="pubmed">35159153</ArticleId></ArticleIdList></Reference><Reference><Citation>Akutsu M, Dikic I, and Bremm A. 2016. Ubiquitin chain diversity at a glance. J. Cell Sci 129: 875&#x2013;880.</Citation><ArticleIdList><ArticleId IdType="pubmed">26906419</ArticleId></ArticleIdList></Reference><Reference><Citation>Emmerich CH, Bakshi S, Kelsall IR, Ortiz-Guerrero J, Shpiro N, and Cohen P. 2016. Lys63/Met1-hybrid ubiquitin chains are commonly formed during the activation of innate immune signalling. Biochem. Biophys Res. Commun 474: 452&#x2013;461.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4880150</ArticleId><ArticleId IdType="pubmed">27133719</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu Y, Xu X, Lin P, He Y, Zhang Y, Cao B, Zhang Z, Sethi G, Liu J, Zhou X, and Mao X. 2019. Inhibition of the deubiquitinase USP9x induces pre-B cell homeobox 1 (PBX1) degradation and thereby stimulates prostate cancer cell apoptosis. J. Biol. Chem 294: 4572&#x2013;4582.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6433065</ArticleId><ArticleId IdType="pubmed">30718275</ArticleId></ArticleIdList></Reference><Reference><Citation>Berthelsen J, Kilstrup-Nielsen C, Blasi F, Mavilio F, and Zappavigna V. 1999. The subcellular localization of PBX1 and EXD proteins depends on nuclear import and export signals and is modulated by association with PREP1 and HTH. Genes Dev. 13: 946&#x2013;953.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC316640</ArticleId><ArticleId IdType="pubmed">10215622</ArticleId></ArticleIdList></Reference><Reference><Citation>Ficara F, Crisafulli L, Lin C, Iwasaki M, Smith KS, Zammataro L, and Cleary ML. 2013. Pbx1 restrains myeloid maturation while preserving lymphoid potential in hematopoietic progenitors. J. Cell Sci 126: 3181&#x2013;3191.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3711206</ArticleId><ArticleId IdType="pubmed">23660001</ArticleId></ArticleIdList></Reference><Reference><Citation>Gu S, Zhang J, Han X, Ding H, Yao C, Ye Z, Yin Z, Hou G, Jiang Y, Qian J, Zhou H, Guo Q, Chen S, Dai D, and Shen N. 2023. The transcriptional factor Pbx1 adjusts peripheral B cell homeostasis to constrain lupus autoimmunity. Arthritis Rheumatol. Mar 2. doi: 10.1002/art.42487. Online ahead of print.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/art.42487</ArticleId><ArticleId IdType="pubmed">36862399</ArticleId></ArticleIdList></Reference><Reference><Citation>Lu S, Zeumer L, Sorensen H, Yang H, Ng Y, Yu F, Riva A, Croker B, Wallet S, and Morel L. 2015. The murine Pbx1-d lupus susceptibility allele accelerates mesenchymal stem cell differentiation and impairs their immunosuppressive function. J. Immunol 194: 43&#x2013;55.</Citation><ArticleIdList><ArticleId IdType="pubmed">25416808</ArticleId></ArticleIdList></Reference><Reference><Citation>Moulton VR, Suarez-Fueyo A, Meidan E, Li H, Mizui M, and Tsokos GC. 2017. Pathogenesis of human systemic lupus erythematosus: A cellular perspective. Trends Mol. Med 23: 615&#x2013;635.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5650102</ArticleId><ArticleId IdType="pubmed">28623084</ArticleId></ArticleIdList></Reference><Reference><Citation>Suarez-Fueyo A, Bradley SJ, Klatzmann D, and Tsokos GC. 2017. T cells and autoimmune kidney disease. Nat. Rev. Nephrol 13: 329&#x2013;343.</Citation><ArticleIdList><ArticleId IdType="pubmed">28287110</ArticleId></ArticleIdList></Reference><Reference><Citation>Ohl K, and Tenbrock K. 2015. Regulatory T cells in systemic lupus erythematosus. Eur. J. Immunol 45: 344&#x2013;355.</Citation><ArticleIdList><ArticleId IdType="pubmed">25378177</ArticleId></ArticleIdList></Reference><Reference><Citation>Li W, Deng C, Yang H, and Wang G. 2019. The regulatory T cell in active systemic lupus erythematosus patients: A systemic review and meta-analysis. Front. Immunol 10: 159.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6387904</ArticleId><ArticleId IdType="pubmed">30833946</ArticleId></ArticleIdList></Reference><Reference><Citation>Yoshimi R, and Nakajima H. 2022. Current state and issues of regenerative medicine for rheumatic diseases. Front. Med 9: 813952.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8831787</ArticleId><ArticleId IdType="pubmed">35155499</ArticleId></ArticleIdList></Reference><Reference><Citation>Niu Y, Sengupta M, Titov AA, Choi SC, and Morel L. 2017. The PBX1 lupus susceptibility gene regulates CD44 expression. Mol. Immunol 85: 148&#x2013;154.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5389453</ArticleId><ArticleId IdType="pubmed">28257976</ArticleId></ArticleIdList></Reference><Reference><Citation>Shen YA, Jung J, Shimberg GD, Hsu FC, Rahmanto YS, Gaillard SL, Hong J, Bosch J, Shih IM, Chuang CM, and Wang TL. 2021. Development of small molecule inhibitors targeting PBX1 transcription signaling as a novel cancer therapeutic strategy. iScience 24: 103297.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8591422</ArticleId><ArticleId IdType="pubmed">34816098</ArticleId></ArticleIdList></Reference><Reference><Citation>Longobardi E, Penkov D, Mateos D, De Florian G, Torres M, and Blasi F. 2014. Biochemistry of the tale transcription factors PREP, MEIS, and PBX in vertebrates. Dev. Dyn 243: 59&#x2013;75.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4232920</ArticleId><ArticleId IdType="pubmed">23873833</ArticleId></ArticleIdList></Reference><Reference><Citation>Abu-Shaar M, Ryoo HD, and Mann RS. 1999. Control of the nuclear localization of Extradenticle by competing nuclear import and export signals. Genes Dev. 13: 935&#x2013;945.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC316638</ArticleId><ArticleId IdType="pubmed">10215621</ArticleId></ArticleIdList></Reference><Reference><Citation>Penkov D, Di Rosa P, Fernandez Diaz L, Basso V, Ferretti E, Grassi F, Mondino A, and Blasi F. 2005. Involvement of Prep1 in the alphabeta T-cell receptor T-lymphocytic potential of hematopoietic precursors. Mol. Cell. Biol 25: 10768&#x2013;10781.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1316969</ArticleId><ArticleId IdType="pubmed">16314502</ArticleId></ArticleIdList></Reference><Reference><Citation>Ren P, Lu L, Cai S, Chen J, Lin W, and Han F. 2021. Alternative splicing: A new cause and potential therapeutic target in autoimmune disease. Front. Immunol 12: 713540.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8416054</ArticleId><ArticleId IdType="pubmed">34484216</ArticleId></ArticleIdList></Reference><Reference><Citation>Keszei M, Detre C, Rietdijk ST, Munoz P, Romero X, Berger SB, Calpe S, Liao G, Castro W, Julien A, Wu YY, Shin DM, Sancho J, Zubiaur M, Morse HC III, Morel L, Engel P, Wang N, and Terhorst C. 2011. A novel isoform of the Ly108 gene ameliorates murine lupus. J. Exp. Med 208: 811&#x2013;822.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3135348</ArticleId><ArticleId IdType="pubmed">21422172</ArticleId></ArticleIdList></Reference><Reference><Citation>Xu Y, Zhao W, Olson SD, Prabhakara KS, and Zhou X. 2018. Alternative splicing links histone modifications to stem cell fate decision. Genome Biol. 19: 133.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6138936</ArticleId><ArticleId IdType="pubmed">30217220</ArticleId></ArticleIdList></Reference><Reference><Citation>Linares AJ, Lin CH, Damianov A, Adams KL, Novitch BG, and Black DL. 2015. The splicing regulator PTBP1 controls the activity of the transcription factor Pbx1 during neuronal differentiation. Elife. 4: e09268.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4755740</ArticleId><ArticleId IdType="pubmed">26705333</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>